Evidence map›Paper›PMID 41177523›Full record

ArticleJournal of obstetric, gynecologic, and neonatal nursing : JOGNN2026

Awareness of the Vaginal Microbiome and Willingness to Undergo Vaginal Microbiota Transplant.

Ellie Kroeger, Caeli Malloy, Chen X Chen, Kaboni Whitney Gondwe, Kendra Kamp

Abstract read
In one paragraph

Article in Journal of obstetric, gynecologic, and neonatal nursing : JOGNN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ellie Kroeger
Caeli Malloy
Chen X Chen
Kaboni Whitney Gondwe
Kendra Kamp

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Omics and Symptom Science Training ProgramT32NR016913 · NINR · UNIVERSITY OF WASHINGTON · PI CYNTHIA M DOUGHERTY, Margaret McLean Heitkemper · 2017 to 2026
$3.2M
Vaginal Microbiome, Inflammatory Mediators, Metabolome, and Dysmenorrhea Symptom-based PhenotypesR01HD110994 · NICHD · UNIVERSITY OF ARIZONA · PI Chen X Chen · 2023 to 2026
$2.5M
A Comprehensive Self-Management Intervention for individuals with Inflammatory Bowel DiseaseK23NR020044 · NINR · UNIVERSITY OF WASHINGTON · PI KAMP, KENDRA JOY · 2022 to 2024
$430k
NCATS NIH HHS UL1 TR002319NICHD NIH HHS R01 HD110994NINR NIH HHS K23 NR020044NINR NIH HHS T32 NR016913
6 · The paper itself

Abstract

objectiveTo examine awareness of the vaginal microbiome and vaginal microbiota transplant, willingness to undergo vaginal microbiota transplant, and factors that influence the decision to undergo the procedure.

designCross-sectional descriptive survey study.

settingOnline distribution from October 2024 to January 2025.

participantsRespondents (N = 210) who self-identified as women (n = 198), men (n = 2), gender nonconforming (n = 14), transgender (n = 3), other (n = 2), and not specified (n = 2) and had vaginas.

methodsThe survey included questions about patient demographics, gynecologic and pelvic symptoms and conditions, and vaginal microbiota transplantation awareness and willingness. We used descriptive statistics to summarize the quantitative data and conducted conventional content analysis to examine responses to open-ended questions about factors to undergo vaginal microbiota transplantation.

resultsMost respondents (n = 176, 83.8%) had not heard of vaginal microbiota transplant. However, more than 50% of respondents were willing or very willing to undergo vaginal microbiota transplantation for each presented indication: prevent yeast infections, bacterial vaginosis, or cytolytic vaginosis (n = 131, 62.4%); reduce risk of sexually transmitted infections (n = 130, 61.9%); alleviate menstrual pain (n = 126, 60.0%); prevent urinary tract infections (n = 126, 60.0%); alleviate vaginal symptoms (n = 120, 57.1%); prevent preterm births (n = 119, 56.7%). We identified five categories from 180 responses about factors that influenced the decision to undergo vaginal microbiota transplantation: Evidence, Procedure Logistics, Health Care Factors, Personal Factors, and Donor Health.

conclusionIncreased awareness about the vaginal microbiome and vaginal microbiota transplantations is necessary. Factors that influence willingness to undergo the procedure should be addressed in designing and implementing this new intervention.

Indexed as

Health Knowledge, Attitudes, PracticeMicrobiotaPatient Acceptance of Health CareVaginaAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and Questionnairesmicrobiotapatient preferencevagina

Identifiers

PMID41177523
PMCPMC12616623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.